- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic Strategies for Targeting Ovarian Cancer Stem Cells
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 10, Pages 5059
Publisher
MDPI AG
Online
2021-05-11
DOI
10.3390/ijms22105059
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characterization of SOX2, OCT4 and NANOG in Ovarian Cancer Tumor-Initiating Cells
- (2021) Mikella Robinson et al. Cancers
- miR-26b regulates cell proliferation and apoptosis of CD117+CD44+ ovarian cancer stem cells by targeting PTEN
- (2021) Zubiao Gao et al. EUROPEAN JOURNAL OF HISTOCHEMISTRY
- CD133+/CD166+ human gastric adenocarcinoma cells present the properties of neoplastic stem cells and emerge more malignant features
- (2021) Tengyang Ni et al. LIFE SCIENCES
- Exosome-mediated transfer of CD44 from high-metastatic ovarian cancer cells promotes migration and invasion of low-metastatic ovarian cancer cells
- (2021) Xiameng Shen et al. Journal of Ovarian Research
- Correlation of PKM2 and CD44 Protein Expression with Poor Prognosis in Platinum-Treated Epithelial Ovarian Cancer: A Retrospective Study
- (2020) Chara Papadaki et al. Cancers
- Carcinoma-Associated Mesenchymal Stem Cells Promote Chemoresistance in Ovarian Cancer Stem Cells via PDGF Signaling
- (2020) Shreya Raghavan et al. Cancers
- Overcoming PARP inhibitor resistance in ovarian cancer: what are the most promising strategies?
- (2020) Daniel Martin Klotz et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Characteristics of CD133-Sustained Chemoresistant Cancer Stem-Like Cells in Human Ovarian Carcinoma
- (2020) Chao Lien Liu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CD44 in Ovarian Cancer Progression and Therapy Resistance—A Critical Role for STAT3
- (2020) Antons Martincuks et al. Frontiers in Oncology
- CD166 promotes cancer stem cell-like phenotype via the EGFR/ERK1/2 pathway in the nasopharyngeal carcinoma cell line CNE-2R
- (2020) Xishan Chen et al. LIFE SCIENCES
- Characterization of a Novel Third-Generation Anti-CD24-CAR against Ovarian Cancer
- (2019) Rüdiger Klapdor et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Hypoxia/pseudohypoxia‐mediated activation of hypoxia‐inducible factor‐1α in cancer
- (2019) Yoshihiro Hayashi et al. CANCER SCIENCE
- Epithelial ovarian cancer: Evolution of management in the era of precision medicine
- (2019) Stephanie Lheureux et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Expression of CD24 in plasma, exosome and ovarian tissue samples of serous ovarian cancer patients
- (2019) Beáta Soltész et al. JOURNAL OF BIOTECHNOLOGY
- Presence and role of stem cells in ovarian cancer
- (2019) Natasa Kenda Suster et al. World Journal of Stem Cells
- Dual‑targeting nanomicelles with CD133 and CD44 aptamers for enhanced delivery of gefitinib to two populations of lung cancer‑initiating cells
- (2019) Xiaolong Huang et al. Experimental and Therapeutic Medicine
- Ovarian cancer stem cells and targeted therapy
- (2019) Vahideh Keyvani et al. Journal of Ovarian Research
- High ALDH activity defines ovarian cancer stem-like cells with enhanced invasiveness and EMT progress which are responsible for tumor invasion
- (2018) Yiying Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
- (2018) Tathiane M. Malta et al. CELL
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Characterization of stem cell and cancer stem cell populations in ovary and ovarian tumors
- (2018) Seema C. Parte et al. Journal of Ovarian Research
- CD133 as a regulator of cancer metastasis through the cancer stem cells
- (2018) Geou-Yarh Liou INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Ovarian cancer stem cell: A potential therapeutic target for overcoming multidrug resistance
- (2018) Aynaz Mihanfar et al. JOURNAL OF CELLULAR PHYSIOLOGY
- PARP inhibition induces enrichment of DNA repair proficient CD133 and CD117 positive ovarian cancer stem cells
- (2018) Chiara Bellio et al. MOLECULAR CANCER RESEARCH
- Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
- (2018) Kathleen Moore et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of Recurrence of Ovarian Cancer on Quality of Life and Outlook for the Future
- (2017) Nicoletta Colombo et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- CD44 as a cancer stem cell marker and its prognostic value in patients with ovarian carcinoma
- (2017) Alena Bartakova et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
- (2017) Eric Pujade-Lauraine et al. LANCET ONCOLOGY
- CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways
- (2017) Kiyoko Nakamura et al. ONCOLOGY REPORTS
- Overexpression of the cancer stem cell marker CD117 predicts poor prognosis in epithelial ovarian cancer patients: evidence from meta-analysis
- (2017) Bikang Yang et al. OncoTargets and Therapy
- Peroxisome Proliferator-Activated Receptors and their Ligands in Cancer Drug- Resistance: Opportunity or Challenge
- (2016) Bahman Yousefi et al. Anti-Cancer Agents in Medicinal Chemistry
- The cancer stem-cell signaling network and resistance to therapy
- (2016) A. Carnero et al. CANCER TREATMENT REVIEWS
- CD44 Expression Level and Isoform Contributes to Pancreatic Cancer Cell Plasticity, Invasiveness, and Response to Therapy
- (2016) Shujie Zhao et al. CLINICAL CANCER RESEARCH
- Autotaxin Regulates Maintenance of Ovarian Cancer Stem Cells through Lysophosphatidic Acid-Mediated Autocrine Mechanism
- (2016) Eun Jin Seo et al. STEM CELLS
- Enrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosis
- (2016) Kongming Wu et al. OncoTargets and Therapy
- Hypoxia-NOTCH1-SOX2 signaling is important for maintaining cancer stem cells in ovarian cancer
- (2016) Eun Jin Seo et al. Oncotarget
- Aldehyde dehydrogenase 1A1 in stem cells and cancer
- (2016) Hiroyuki Tomita et al. Oncotarget
- Cisplatin induces stemness in ovarian cancer
- (2016) Andrew Wiechert et al. Oncotarget
- CD133, Selectively Targeting the Root of Cancer
- (2016) Jörg Schmohl et al. Toxins
- The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer
- (2016) Ranjeeta Thapa et al. Stem Cells International
- ALCAM is a Novel Cytoplasmic Membrane Protein in TNF-α Stimulated Invasive Cholangiocarcinoma Cells
- (2015) Poom Adisakwattana et al. Asian Pacific Journal of Cancer Prevention
- Molecular mechanisms of drug resistance and its reversal in cancer
- (2015) Melis Kartal-Yandim et al. CRITICAL REVIEWS IN BIOTECHNOLOGY
- Translational potential of cancer stem cells: A review of the detection of cancer stem cells and their roles in cancer recurrence and cancer treatment
- (2015) Farhadul Islam et al. EXPERIMENTAL CELL RESEARCH
- Predictive markers of chemoresistance in advanced stages epithelial ovarian carcinoma
- (2015) Claire Bonneau et al. GYNECOLOGIC ONCOLOGY
- Hypoxia-induced cell stemness leads to drug resistance and poor prognosis in lung adenocarcinoma
- (2015) Mingchuan Zhao et al. LUNG CANCER
- CD24+ Ovarian Cancer Cells Are Enriched for Cancer-Initiating Cells and Dependent on JAK2 Signaling for Growth and Metastasis
- (2015) D. Burgos-Ojeda et al. MOLECULAR CANCER THERAPEUTICS
- The cancer stem cell gamble
- (2015) J. Kaiser SCIENCE
- CD133+ ovarian cancer stem-like cells promote non-stem cancer cell metastasis via CCL5 induced epithelial-mesenchymal transition
- (2015) Haixia Long et al. Oncotarget
- Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target
- (2015) Yongmin Yan et al. Stem Cells Translational Medicine
- CD44v8-10 Is a Cancer-Specific Marker for Gastric Cancer Stem Cells
- (2014) W. M. Lau et al. CANCER RESEARCH
- ALCAM/CD166 Is a TGF- -Responsive Marker and Functional Regulator of Prostate Cancer Metastasis to Bone
- (2014) A. G. Hansen et al. CANCER RESEARCH
- Cancer stem cells - important players in tumor therapy resistance
- (2014) Selcuk Colak et al. FEBS Journal
- Cluster of Differentiation 166 (CD166) Regulated by Phosphatidylinositide 3-Kinase (PI3K)/AKT Signaling to Exert Its Anti-apoptotic Role via Yes-associated Protein (YAP) in Liver Cancer
- (2014) Lifang Ma et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CD166 plays a pro-carcinogenic role in liver cancer cells via inhibition of FOXO proteins through AKT
- (2014) WENJUN YU et al. ONCOLOGY REPORTS
- Ovarian Cancer Spheroid Cells with Stem Cell-Like Properties Contribute to Tumor Generation, Metastasis and Chemotherapy Resistance through Hypoxia-Resistant Metabolism
- (2014) Jianqun Liao et al. PLoS One
- ALDH1A1 Maintains Ovarian Cancer Stem Cell-Like Properties by Altered Regulation of Cell Cycle Checkpoint and DNA Repair Network Signaling
- (2014) Erhong Meng et al. PLoS One
- Surface Markers of Cancer Stem Cells in Solid Tumors
- (2014) Pu Xia Current Stem Cell Research & Therapy
- Comparison of Mesenchymal Stem Cell Markers in Multiple Human Adult Stem Cells
- (2014) Masoud Maleki et al. International Journal of Stem Cells
- Coming into focus: the nonovarian origins of ovarian cancer
- (2013) L. Dubeau et al. ANNALS OF ONCOLOGY
- Isolation and Characterization of Intestinal Stem Cells Based on Surface Marker Combinations and Colony-Formation Assay
- (2013) Fengchao Wang et al. GASTROENTEROLOGY
- CD44 standard form expression is correlated with high-grade and advanced-stage ovarian carcinoma but not prognosis
- (2013) Jing Zhang et al. HUMAN PATHOLOGY
- The CDK1 inhibitor RO3306 improves the response of BRCA-proficient breast cancer cells to PARP inhibition
- (2013) QING XIA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
- (2013) Gregg L. Semenza JOURNAL OF CLINICAL INVESTIGATION
- Plasma Membrane Proteomics of Tumor Spheres Identify CD166 as a Novel Marker for Cancer Stem-like Cells in Head and Neck Squamous Cell Carcinoma
- (2013) Ming Yan et al. MOLECULAR & CELLULAR PROTEOMICS
- Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden
- (2013) Khalid Abubaker et al. Molecular Cancer
- Unknown
- (2013) Hua Jiang et al. MOLECULAR MEDICINE
- Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche
- (2013) Andrea Flesken-Nikitin et al. NATURE
- ALDH1-Bright Epithelial Ovarian Cancer Cells Are Associated with CD44 Expression, Drug Resistance, and Poor Clinical Outcome
- (2012) Yu-Chi Wang et al. AMERICAN JOURNAL OF PATHOLOGY
- Role of the autotaxin–lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapy
- (2012) David N. Brindley et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- The hypoxic microenvironment upgrades stem-like properties of ovarian cancer cells
- (2012) Dongming Liang et al. BMC CANCER
- Glycine Decarboxylase Activity Drives Non-Small Cell Lung Cancer Tumor-Initiating Cells and Tumorigenesis
- (2012) Wen Cai Zhang et al. CELL
- CD44+/CD24− ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival
- (2012) Erhong Meng et al. CLINICAL & EXPERIMENTAL METASTASIS
- Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization
- (2012) Virginia Tirino et al. FASEB JOURNAL
- Lysophosphatidic acid-induced ADAM12 expression mediates human adipose tissue-derived mesenchymal stem cell-stimulated tumor growth
- (2012) Eun Kyoung Do et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Cancer stem cells
- (2012) Zuoren Yu et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges
- (2012) Philipp Grosse-Gehling et al. JOURNAL OF PATHOLOGY
- Embryonic Stem Cell Markers
- (2012) Wenxiu Zhao et al. MOLECULES
- c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin–ATP-binding cassette G2 signaling
- (2012) W K Chau et al. ONCOGENE
- Stem-Like Epithelial Cells Are Concentrated in the Distal End of the Fallopian Tube: A Site for Injury and Serous Cancer Initiation
- (2012) Daniel Y. Paik et al. STEM CELLS
- Periostin mediates human adipose tissue-derived mesenchymal stem cell-stimulated tumor growth in a xenograft lung adenocarcinoma model
- (2011) Soon Chul Heo et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- CD44 Variant Regulates Redox Status in Cancer Cells by Stabilizing the xCT Subunit of System xc− and Thereby Promotes Tumor Growth
- (2011) Takatsugu Ishimoto et al. CANCER CELL
- HIF Induces Human Embryonic Stem Cell Markers in Cancer Cells
- (2011) J. Mathieu et al. CANCER RESEARCH
- Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance
- (2011) Ayesha B. Alvero et al. CELL CYCLE
- Cancer Stem Cells and Chemosensitivity
- (2011) M. Maugeri-Sacca et al. CLINICAL CANCER RESEARCH
- CD133 expression associated with poor prognosis in ovarian cancer
- (2011) Jing Zhang et al. MODERN PATHOLOGY
- Histologic, Molecular, and Cytogenetic Features of Ovarian Cancers: Implications for Diagnosis and Treatment
- (2011) Neeraj Lalwani et al. RADIOGRAPHICS
- Ovarian Cancer Development and Metastasis
- (2010) Ernst Lengyel AMERICAN JOURNAL OF PATHOLOGY
- The AC133 Epitope, but not the CD133 Protein, Is Lost upon Cancer Stem Cell Differentiation
- (2010) K. Kemper et al. CANCER RESEARCH
- A Myc Network Accounts for Similarities between Embryonic Stem and Cancer Cell Transcription Programs
- (2010) Jonghwan Kim et al. CELL
- Characterization of the Intestinal Cancer Stem Cell Marker CD166 in the Human and Mouse Gastrointestinal Tract
- (2010) Trevor G. Levin et al. GASTROENTEROLOGY
- Targeting melanoma growth and viability reveals dualistic functionality of the phosphonothionate analogue of carba cyclic phosphatidic acid
- (2010) Molly K Altman et al. Molecular Cancer
- Autotaxin expression and its connection with the TNF-alpha-NF-κB axis in human hepatocellular carcinoma
- (2010) Jian-Min Wu et al. Molecular Cancer
- The Cancer Stem Cell Hypothesis
- (2010) Maryam Rahman et al. NEUROSURGERY
- CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells
- (2010) M-Q Gao et al. ONCOGENE
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
- (2010) A Singh et al. ONCOGENE
- Mullerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeutics
- (2010) X. Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer stem cells from colorectal cancer-derived cell lines
- (2010) Trevor M. Yeung et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse
- (2009) C Kahlert et al. BRITISH JOURNAL OF CANCER
- Prognostic Significance of the Cancer Stem Cell Markers CD133, CD44, and CD166 in Colorectal Cancer
- (2009) David Horst et al. CANCER INVESTIGATION
- Expression of Autotaxin and Acylglycerol kinase in prostate cancer: Association with cancer development and progression
- (2009) Mohammed Ahmed Abdel Muneem Nouh et al. CANCER SCIENCE
- First-line treatment of advanced ovarian cancer: current research and perspectives
- (2009) Claudia Marchetti et al. Expert Review of Anticancer Therapy
- Production of offspring from a germline stem cell line derived from neonatal ovaries
- (2009) Kang Zou et al. NATURE CELL BIOLOGY
- Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
- (2008) S. Zhang et al. CANCER RESEARCH
- Lysophosphatidic acid induces cell migration through the selective activation of Akt1
- (2008) Eun Kyoung Kim et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors
- (2008) Ittai Ben-Porath et al. NATURE GENETICS
- CD marker expression profiles of human embryonic stem cells and their neural derivatives, determined using flow-cytometric analysis, reveal a novel CD marker for exclusion of pluripotent stem cells
- (2008) Maria Sundberg et al. Stem Cell Research
- Aldehyde Dehydrogenase as a Marker for Stem Cells
- (2008) Jan Moreb Current Stem Cell Research & Therapy
- Lysophosphatidic acid in malignant ascites stimulates migration of human mesenchymal stem cells
- (2007) Mi Jeong Lee et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Cancer-Derived Lysophosphatidic Acid Stimulates Differentiation of Human Mesenchymal Stem Cells to Myofibroblast-Like Cells
- (2007) Eun Su Jeon et al. STEM CELLS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started